Bevacizumab plus erlotinib combination for advanced HLRCC
A recent study, published in Cancer Research and Treatment in [...]
A recent study, published in Cancer Research and Treatment in [...]
Results from this trial for patients with non-clear cell renal [...]
A recent phase 2 study evaluated the combination of bevacizumab [...]
The combined safety results of two studies with the atezolizumab [...]
A recent study published in Clinical Cancer Research and conducted in [...]
Patient-reported outcomes from the phase 3 IMmotion151 study, which assessed [...]
The following is a Practice Update interview with Dr Hans Hammers, Associate [...]
The combination of immunotherapy atezolizumab (Tecentriq) with targeted therapy bevacizumab [...]
Interim results from the phase III IMmotion151 study to assess [...]
In this interview, Dr Daniel George from the Duke Cancer Institute, Durham, [...]